GO
Loading...

Law

More

  • Singapore GIC cuts stake in Bunge to 1.73 pct-filing Thursday, 13 Feb 2014 | 8:03 PM ET

    SINGAPORE, Feb 14- Singapore sovereign wealth fund GIC has cut its stake in commodities trader Bunge Ltd to 1.73 percent from 4.99 percent a year earlier, according to a U.S. regulatory filing. GIC, which had built up its stake in Bunge close to 5 percent in 2012, cut its holding after Bunge's share price jumped about 13 percent in 2013..

  • NEW YORK, Feb 13- The only three insurance companies in Louisiana that sell healthcare policies under President Barack Obama's healthcare law throughout the state are rejecting payments from a federal program intended to help low-income HIV patients, advocacy groups said on Thursday.

  • WASHINGTON, Feb 13- Japan's Bridgestone Corp has agreed to plead guilty and to pay a $425 million criminal fine for its role in a conspiracy to fix prices on certain automotive parts, the U.S. Department of Justice said on Thursday.

  • NEW YORK, Feb 13- A U.S. federal judge has chosen the law firm Scott+ Scott LLP to serve as interim lead counsel in a consolidated class action against many of the world's largest banks alleging manipulation of the roughly $5.3 trillion- a-day foreign exchange market.

  • Comcast deal 'too big to sail' past feds: Hundt Thursday, 13 Feb 2014 | 12:28 PM ET

    Regulators are likely to zero in on Comcast-Time Warner Cable's commitment to an open Internet, a former FCC chairman told CNBC.

  • SYDNEY, Feb 13- Australia's competition regulator said on Thursday it was taking legal action against the local division of Pfizer Inc over the way it marketed its cholesterol-lowering drug Lipitor to pharmacies.

  • Ex-New Orleans mayor convicted of taking bribes Wednesday, 12 Feb 2014 | 2:36 PM ET
    Former New Orleans Mayor Ray Nagin.

    Former New Orleans Mayor Ray Nagin was convicted Wednesday on charges that he accepted bribes, free trips and other gratuities from contractors.

  • Feb 12- U.S. health regulators on Wednesday approved the Johnson& Johnson and Pharmacyclics Inc cancer drug Imbruvica to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer.

  • J&J, Pharmacyclics drug gets U.S. approval for leukemia Wednesday, 12 Feb 2014 | 1:19 PM ET

    Feb 12- U.S. health regulators on Wednesday approved the Johnson& Johnson and Pharmacyclics Inc cancer drug Imbruvica to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer. The Food and Drug Administration decision marks the second approval recently for the medicine, known chemically as ibrutinib.

  • With Khodorkovsky out, Yukos investors fight on Wednesday, 12 Feb 2014 | 9:56 AM ET

    *Two big cases against Russia could be resolved this year. MOSCOW, Feb 12- Freed former tycoon Mikhail Khodorkovsky has ruled out trying to recover the fortune that made him Russia's richest man, but two multi-billion-dollar law suits involving his defunct oil giant Yukos could be decided this year.

  • How former DEA agents became pot proponents Wednesday, 12 Feb 2014 | 9:10 AM ET
    DEA agent Paul Schmidt (center) receives honors for his work.

    Paul Schmidt and Patrick Moen fought in the drug war as DEA agents. They have now given up their badges to work in the nascent cannabis industry.

  • Wanted: FBI offers $10,000 for 'laser strike' info Wednesday, 12 Feb 2014 | 8:41 AM ET

    The FBI will pay $10,000 for information that helps catch individuals that intentionally point lasers at aircraft.

  • RPT-Critics claim Volcker rule skirts cost-benefit laws Wednesday, 12 Feb 2014 | 7:00 AM ET

    Lawyers for the business lobby group are combing through the 1995 Unfunded Mandates Reform Act, which the Office of the Comptroller of the Currency has said directs it to assess the economic impact of any new rule that will cost the government or private sector $100 million or more.

  • WILMINGTON, Del., Feb 12- A judge who found what he called a "startling pattern" of abuse by plaintiffs' lawyers may have shifted the landscape of asbestos litigation with a ruling in favor of manufacturers.

  • Regulator scopes Transurban bid for Queensland Motorways Wednesday, 12 Feb 2014 | 1:27 AM ET

    SYDNEY, Feb 12- Australia's competition regulator said on Wednesday it was inviting feedback on whether Transurban Group, the country's biggest toll road operator, should be allowed to buy about A $5 billion of roads from the Queensland state government.

  • Thanks to a longstanding legal exemption that Fed officials say limits their regulatory capacity, Morgan Stanley and Goldman Sachs may yet emerge from the regulatory upheaval that is upending banks' commodities trading better-off than their peers, who face potentially tougher new rules.

  • CARACAS, Feb 11- Venezuelan President Nicolas Maduro on Tuesday said his government in the coming hours would reform currency exchange regulations to allow for a new foreign exchange platform under the OPEC nation's currency controls.

  • CARACAS, Feb 11- Venezuelan President Nicolas Maduro on Tuesday said his government in coming hours would reform currency exchange regulations to allow for a new foreign exchange platform under the OPEC nation's currency controls. The new system would complement the foreign exchange auction system known as Sicad, Maduro said.

  • Feb 11- The Obama administration may have pushed the bounds of its legal authority by delaying the healthcare law requirement that certain employers provide coverage to full-time workers, but the move will be tough to challenge in court, according to legal experts.

  • Feb 11- Western Union Co said it expects the high compliance costs that hit its earnings in the fourth quarter to ease in 2014, helping to push up the company's shares after the bell. Western Union said in October that it did not expect earnings growth in 2014 due to higher compliance costs, which it pegged at 3.5-4.5 percent of revenue.

Contact Law

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More